The triple negative tumour phenotype in breast cancer was statistically associated to 9–12 del BRCA1 carriers, when compared with the group of non-carriers (73% versus 21%, p = 0.0005; two-sided Fisher's exact test). This evidence concerns the gene BRCA1 and breast carcinoma.